Managing Patients Following a Negative Prostate Biopsy

February 2011
Renal & Urology News;Feb2011, Vol. 10 Issue 2, p23
The article addresses several issues affecting the scenario posed by patients who have undergone repeat biopsy for prostate cancer in the U.S. It stresses that urologists need to consider several factors when deciding a repeat biopsy which is more likely to indicate cancer because the previous tests missed its location. It also discusses the impact of high-grade prostatic intraepithelial neoplasia (HGPIN) on the likelihood of finding undiagnosed prostate cancer.


Related Articles

  • Little of no residual prostate cancer at radical prostatectomy. Kumar, R.; Yadav, R. // Indian Journal of Urology;Jan-Mar2006, Vol. 22 Issue 1, p83 

    Following a needle biopsy diagnosis of prostate cancer, occasionally, no residual cancer can be identified in the radical prostatectomy specimen. Such cancers have been referred to as the 'Vanishing cancer phenomenon'. This raises the question as to whether the initial biopsy and subsequent...

  • Perform a follow-up prostate biopsy even when the first is negative.  // Modern Medicine;Oct97, Vol. 65 Issue 10, p10 

    Focuses on the study recommending a second transrectal ultrasound-guided needle biopsy of the prostate when the first biopsy is negative. Target on men with high levels of prostate-specific antigen; Failure to identify small cancers during the first biopsy.

  • The effect of urologist experience on choosing active surveillance for prostate cancer. Chu, William; Kim, Brian; Slezak, Jeff; Harrison, Teresa; Gelfond, Joy; Jacobsen, Steven; Chien, Gary // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1701 

    Purpose: To evaluate the impact of the urologist's experience in selecting active surveillance (AS) versus immediate treatment (IT) for low-risk prostate cancer. Methods: Men with low-risk prostate cancer were enrolled from March 2011 to August 2013 at 13 medical centers in Kaiser Permanente...

  • Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results. Tewes, Susanne; Hueper, Katja; Hartung, Dagmar; Imkamp, Florian; Herrmann, Thomas; Weidemann, Juergen; Renckly, Stefan; Kuczyk, Markus; Wacker, Frank; Peters, Inga // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1707 

    Purpose: To evaluate a novel system for MRI/TRUS fusion-guided biopsy for detection of prostate cancer (PCa) in patients with previous negative prostate biopsy and determine diagnostic accuracy when using the Prostate Imaging Reporting and Data System (PI-RADS) for multiparametric magnetic...

  • An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? Feletto, E.; Bang, A.; Cole-Clark, D.; Chalasani, V.; Rasiah, K.; Smith, D. // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1677 

    Purpose: To compare prostate cancer incidence and mortality rates in Australia, USA, Canada and England and quantify the gap between observed prostate cancer deaths in Australia and expected deaths, using US mortality rates. Methods: Analysis of age-standardised prostate cancer incidence and...

  • Diagnosis of adenocarcinoma in prostate needle biopsy tissue.  // Journal of Clinical Pathology;Jan2007, Vol. 60 Issue 1, p35 

    Prostate cancer is a major public health problem throughout the developed world. For patients with clinically localised prostate cancer, the diagnosis is typically established by histopathological examination of prostate needle biopsy samples. Major and minor criteria are used to establish the...

  • A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center. Becker, Andreas; Seiler, Daniel; Kwiatkowski, Maciej; Kluth, Luis; Schnell, Dietrich; Graefen, Markus; Schlomm, Thorsten; Fisch, Margit; Recker, Franz; Weissbach, Lothar; Chun, Felix // World Journal of Urology;Aug2014, Vol. 32 Issue 4, p891 

    Objectives: To date, evidence on active surveillance (AS) is restricted to protocol-based studies. Conversely, practice patterns outside of such protocols are unknown. The aim of this study was to capture the current AS treatment patterns for localized prostate cancer in patients managed by...

  • Prostat iÄŸne biyopsisi ve radikal prostatektomi materyallerinde gleason skorlarının karşılaÅŸtırılması. Kürşat Bozkurt, Kemal; Kızmaz, Mustafa; İnan Mamak, Gülsün; Korkmaz, İsmail; Bircan, Sema // Medical Journal of Suleyman Demirel University;2013, Vol. 20 Issue 3, p93 

    Aim: Gleason score (GS) is an important prognostic marker for prostate cancer and it is strongly correlated with stage and prognosis. However, needle biopsy (NB) GS is not always consistent with that of radical prostatectomy (RP) specimens. In this study, the correlation of GSs of NB and RP...

  • Diagnosis of Prostatic Carcinoma After Therapy: Review 2007. Bostwick, David G.; Meiers, Isabelle // Archives of Pathology & Laboratory Medicine;Mar2007, Vol. 131 Issue 3, p360 

    Context.—Prostate cancer is the most common cancer of men in the United States and is third only to lung and colon cancer as a cause of cancer death. In 2006, 27 350 Americans will die of prostate cancer, and 234 460 new cases will be diagnosed. Treatment changes in the benign and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics